The synthesis and characterization of a new (E,E)-dioxime and its mono and heterotrinuclear complexes containing dioxadithiadiazamacrobicyclic moieties

A new (E,E)-dioxime (2Z,3Z)-1,4,7,8,15,16-hexahydro-9,14-(ethanothioethanothioethano)quinoxalino[6,7-e] [4,7,1,10]benzodioxadiazacyclododecine-2,3,19,26-tetrone2,3-dioxime (H2L) has been synthesized by reacting cyanogen-di-N-oxide with 2,3-diamino-6,7,14,15-tetrahydro-8,13-(ethanothioethanothioethano)dibenzo[b,h] [1,4,7,10]dioxadiazacyclodecine-17,24-dione (6). Mononuclear complexes (8, 9) of this ligand have been synthesized by reacting the vic-dioxime (H2L) with NiCl(2)(.)6H(2)O and CoCl(2)(.)6H(2)O respectively. The BF2+ capped cobalt(111) complex (10) of the new (E,E) vic-dioxime has been synthesized by using as precursor a hydrogen-bridged mononuclear cobalt(III) complex (9). The heterotrinuclear complex (11) has been prepared by reacting one mononuclear cobalt(III) complex (10) with [Cu(MeCN)(4)]PF6. The new compounds were characterized by a combination of elemental analysis, H-1- and C-13-n.m.r, i.r. and m.s. spectral data.